Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
1 other identifier
interventional
132
1 country
1
Brief Summary
To explore whether serial changes of data in body composition of patients with sepsis can help clinician to monitor prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable sepsis
Started Aug 2020
Typical duration for not_applicable sepsis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
August 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2023
CompletedSeptember 1, 2023
August 1, 2023
2.6 years
July 1, 2021
August 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
ICU mortality
Status of survival or mortality at the time discharged from ICU
The day discharged from ICU, an average of 2 weeks
Hospital mortality
Status of survival or mortality at the time discharged from hospital
The day discharged from hospital, an average of 5 weeks
7-day mortality
Status of survival or mortality at Day 7 during hospital stay
Day 7 after hospital admission
28-day mortality
Status of survival or mortality at Day 28 during hospital stay
Day 28 after hospital admission
90-day mortality
Status of survival or mortality at Day 90 during hospital stay
Day 90 after hospital admission
Secondary Outcomes (29)
Change of white blood cell between day 1 and day 3
Day 1 and Day 3 after ICU admission
Change of white blood cell between day 1 and day 8
Day 1 and Day8 after ICU admission
Change of white blood cell between day 3 and day 8
Day 3 and Day 8 after ICU admission
Change of pulse pressure between day 1 and day 3
Day 1 and Day 3 after ICU admission
Change of pulse pressure between day 1 and day 8
Day 1 and Day 8 after ICU admission
- +24 more secondary outcomes
Study Arms (2)
control
NO INTERVENTIONThe investigators will use the random number generator to divide the patients into two groups, the control group (with no nutritional intervention) and the intervention group (with nutritional intervention). The body composition data (of day 1, 3, 8) of the patients in the control group will not be given to the dietitians for adjusting the diet formula according to the patient's body composition.
nutritional intervention
EXPERIMENTALThe investigators will use the random number generator to divide the patients into two groups, the control group (with no nutritional intervention) and the intervention group (with nutritional intervention). The body composition data (of day 1, 3, 8) of the patients in the intervention group will be given to the dietitians for adjusting the diet formula according to the patient's body composition.
Interventions
In the intervention group, the body composition data (of day 1, 3, 8) will be given to the dietitians for adjusting the diet formula. The diet formula will be adjusted on the discretion of the dietitian caring for the septic patients based on clinical judgement. The policy adopted by the dietary treatment guidelines for sepsis is to adjust the dietary concentration when there is too much extracellular water under the premise of gastrointestinal tolerance. When the skeletal muscle mass loss is too fast, the dietitians will increase the protein intake by 1.2g/kg of body weight. For patients with acute renal failure and excess extracellular water accumulation and muscle loss, the dietitians will adjust the protein, sodium, potassium, calcium and phosphorus content in the formula. The dietitians will give appropriate nutrition prescriptions based on clinical signs, disease diagnosis and biochemical values.
Eligibility Criteria
You may qualify if:
- ICU patient
- Clinical diagnosis of sepsis
You may not qualify if:
- \. Expired within 3-days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 83301, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
FANG WEN-FENG
Chang Gung Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2021
First Posted
August 4, 2021
Study Start
August 1, 2020
Primary Completion
March 19, 2023
Study Completion
April 28, 2023
Last Updated
September 1, 2023
Record last verified: 2023-08